Transasia Bio-Medicals
Buying intent
29 tracked signals | Top 15 topics are below | Product and Support are carrying most of it.
Attention by team
LinkedIn activity, by teamWhere Transasia Bio-Medicals's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
29d ago
14d ago
29d ago
18d ago
29d ago
18d ago
14d ago
18d ago
7d ago
30d ago
29d ago
18d ago
20d ago
14d ago
7d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph — including themes not shown on this page.
Who's active at Transasia Bio-Medicals
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
Primary products / business lines
LinkedIn company profileIncepted in the year 1979, Transasia Bio-Medicals Ltd., is headquartered in Mumbai, India. It is recognized as India’s Largest In-vitro Diagnostic Company and offers solutions and products in Biochemistry, Hematology, Coagulation, ESR, Immunology, Urinalysis, Critical Care, Diabetes Management, Microbiology and Molecular Diagnostics. Accurate and quality diagnostics can make all the difference i
Top accounts researching Transasia Bio-Medicals
names withheld on the public pageThese are companies whose own people brought up Transasia Bio-Medicals unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
6,524 companies · 23,607 people are researching Health Care
Transasia Bio-Medicals's own team shows 2 signals on this topic. No one outside Transasia Bio-Medicals has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- Quality Management2,143 cos · 8,017 people
- Medical Technology803 cos · 2,489 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
Buying committee functions
Employee job titles (LinkedIn)Marketing — 1 person; Product — 1 person
What's been said
public posts by Transasia Bio-Medicals's teamNo public post naming Transasia Bio-Medicals has surfaced in the past year, so this is what Transasia Bio-Medicals's own team is posting about publicly — their topics, in their words.
10 cities. 5 countries. 10 days. Year-ends are for several things: celebration, reflection, gratitude, and setting the tone for new beginnings. For this past year, Erba-Transasia story is simple: Growth is back. And it is real. In FY25-26, INR revenues grew 13% — after three years of flatlining. Entirely organic. India and International, both grew in double digits. EBITDA was up 27%. Margins expanded across geographies. International business — historically in cash losses — has fully turned around. Erba-Transasia 2.0 is about steady execution. Boring, but detailed. Strong governance, KPIs and trackers. Hopefully not micromanagement, but certainly micro tracking. The past two weeks were a blur, meeting employees across India — Mumbai, Siliguri, Goa, Indore, Delhi… and across our international offices in Eastern Europe (our factory is in Czech and Russia, R&D centres in France and Austria, and HQ in Dubai). See pictures. But one thing was starkly clear: the energy of our people. 2,000 colleagues. One shared belief, one zeitgeist: we are building something that matters. Our founder’s vision remains our compass: Build a healthier, happier world. We provide Innovative, Reliable and yet Affordable diagnostic solutions. As a young man, he spent 9 years volunteering — unpaid — with the Moral Rearmament Movement led by Rajmohan Gandhi (Gandhiji's grandson). Purpose before profit. Conviction before comfort. Our ambition is clear: to build a true Indian MNC, amongst Top 20 Global IVD companies — one that makes India self-reliant and proud. If India can be the pharmacy of the world, why not a leader in medical devices too? Affordable. High-quality. Global. Today, 1.4 billion laboratory tests every year run on Erba machines, across 80 countries. Equal to 1 test for every Indian. A dream come true. A quiet number. A powerful impact. Suresh Vazirani Shiraz Bugwadia Dr. Sanjay Arora Rajendra Gandhi
Apr 2026Excited to welcome more customers to the NIHON KOHDEN INDIA family! Thank you for trusting our innovative and reliable solutions to advance healthcare and improve patient outcomes. Together, we’re driving excellence in medical technology. #NihonKohden #HealthcareInnovation "
Apr 2026